Cargando…
miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein
Our previous study revealed that microRNA (miR) −30c represents a potential tumor suppressor gene, the expression of which is associated with decreased oncogenic potential in prostate cancer (PCa) cell lines. However, the functional role and underlying mechanisms of miR-30c in PCa remain to be fully...
Autores principales: | Huang, Ya-Qiang, Ling, Xiao-Hui, Yuan, Run-Qiang, Chen, Zhi-Yun, Yang, Sheng-Bang, Huang, Hong-Xing, Zhong, Wei-De, Qiu, Shao-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548014/ https://www.ncbi.nlm.nih.gov/pubmed/28677791 http://dx.doi.org/10.3892/mmr.2017.6910 |
Ejemplares similares
-
Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF
por: Chen, Zhiqi, et al.
Publicado: (2010) -
XE7: A novel splicing factor that interacts with ASF/SF2 and ZNF265
por: Mangs, A. Helena, et al.
Publicado: (2006) -
Deletion of the N-terminus of SF2/ASF Permits RS-Domain-Independent Pre-mRNA Splicing
por: Shaw, Stephanie D., et al.
Publicado: (2007) -
Regulation of Human Neurotropic JC Virus Replication by Alternative Splicing Factor SF2/ASF in Glial Cells
por: Sariyer, Ilker Kudret, et al.
Publicado: (2011) -
Identification of Nuclear and Cytoplasmic mRNA Targets for the Shuttling Protein SF2/ASF
por: Sanford, Jeremy R., et al.
Publicado: (2008)